Struc­ture Ther­a­peu­tics 'en­cour­aged' by 5.4% weight loss with its oral GLP-1, plans for more stud­ies

Struc­ture Ther­a­peu­tics is throw­ing its oral GLP-1 in­to the weight loss ring with promis­ing — al­beit ear­ly and small — da­ta from a Phase Ib tri­al in­ves­ti­gat­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER